Skip to content

Clinical trials

Phase 3 Hemorrhage trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Country / region: Japan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20095
20141
20151
20161
20201
20222
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc4
Pfizer3
Boehringer Ingelheim2
Regeneron Pharmaceuticals2
Takeda2
Alexion Pharmaceuticals, Inc.1
Fresenius Kabi Japan1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage16
Venous Thromboembolism5
Hemophilia A3
Hemophilia B3
Venous Thrombosis3
Autoimmune Diseases2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemorrhagic Disorders2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.